성인 ADHD (Korean Wikipedia)

Analysis of information sources in references of the Wikipedia article "성인 ADHD" in Korean language version.

refsWebsite

Global rank Korean rank

46nih.gov

4^th place

42doi.org

2^nd place

3^rd place

16semanticscholar.org

11^th place

310^th place

7archive.org

6^th place

18^th place

6web.archive.org

1^st place

5worldcat.org

5^th place

11^th place

4books.google.com

3^rd place

9^th place

2webmd.com

1,169^th place

735^th place

2cdc.gov

218^th place

52^nd place

1additudemag.com

low place

1nasponline.org

low place

1sagepub.com

731^st place

373^rd place

1lww.com

2,769^th place

1,748^th place

1neuropsychiatryreviews.com

low place

1uga.edu

2,385^th place

3,631^st place

1dsm5.org

low place

5,395^th place

1harvard.edu

18^th place

27^th place

1aafp.org

1,916^th place

987^th place

1caddra.ca

low place

1archives-ouvertes.fr

1,031^st place

1,010^th place

1doctorlisafairweather.com

low place

1eeoc.gov

low place

1ed.gov

576^th place

1,311^th place

1ama-assn.org

3,257^th place

2,201^st place

1healingwell.com

low place

aafp.org

Searight HR, Burke JM, Rottnek F (November 2000). “Adult ADHD: evaluation and treatment in family medicine”. 《American Family Physician》 62 (9): 2077–86, 2091–2. PMID 11087189.

additudemag.com

ADDitude Magazine; - Attention Deficit > ADD Symptoms & Statistics Is it ADHD? Checklist of 18 ADHD Symptoms Do you have ADD?

ama-assn.org

“Breaking News: The Social and Economic Impact of ADHD”. 《American Medical Association》. 2004년 9월 7일. 2004년 10월 22일에 원본 문서에서 보존된 문서.

archive.org

Anastopoulos AD, Shelton TL (2001년 5월 31일). 《Assessing attention-deficit/hyperactivity disorder》. Topics in Social Psychiatry. New York: Kluwer Academic/Plenum Publishers. ISBN 978-0-306-46388-4. OCLC 51784126.
Kieling C, Kieling RR, Rohde LA, Frick PJ, Moffitt T, Nigg JT, 외. (January 2010). “The age at onset of attention deficit hyperactivity disorder”. 《The American Journal of Psychiatry》 167 (1): 14–6. doi:10.1176/appi.ajp.2009.09060796. PMC 4478075. PMID 20068122.
Moffitt TE, Houts R, Asherson P, Belsky DW, Corcoran DL, Hammerle M; 외. (2015). “Is Adult ADHD a Childhood-Onset Neurodevelopmental Disorder? Evidence From a Four-Decade Longitudinal Cohort Study.”. 《Am J Psychiatry》 172 (10): 967–77. doi:10.1176/appi.ajp.2015.14101266. PMC 4591104. PMID 25998281. CS1 관리 - 여러 이름 (링크)
Kessler RC, Adler L, Barkley R, Biederman J, Conners CK, Demler O, 외. (April 2006). “The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication”. 《The American Journal of Psychiatry》 163 (4): 716–23. doi:10.1176/appi.ajp.163.4.716. PMC 2859678. PMID 16585449.
Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA (June 2007). “The worldwide prevalence of ADHD: a systematic review and metaregression analysis”. 《The American Journal of Psychiatry》 164 (6): 942–8. doi:10.1176/appi.ajp.164.6.942. PMID 17541055.
Conrad P (2007). 《The Medicalization of Society》. Baltimore, Maryland: Johns Hopkins University Press. 66쪽. ISBN 978-0801885853.
Cormier E (October 2008). “Attention deficit/hyperactivity disorder: a review and update”. 《Journal of Pediatric Nursing》 23 (5): 345–57. doi:10.1016/j.pedn.2008.01.003. PMID 18804015.

archives-ouvertes.fr

hal.archives-ouvertes.fr

Berrios GE (December 2006). “'Mind in general' by Sir Alexander Crichton” (PDF). 《History of Psychiatry》 17 (68 Pt 4): 469–86. doi:10.1177/0957154x06071679. PMID 17333675. S2CID 6101515.

books.google.com

Hechtman, Lily (2009년 2월 8일). 〈ADHD in Adults〉. Brown, Thomas E. 《ADHD Comorbidities: Handbook for ADHD Complications in Children and Adults》 1판. Washington, DC: American Psychiatric Publishing. 87쪽. ISBN 9781585628339. OCLC 701833161.
Rettew DC, Hudziak JJ (2009). 〈Genetics of ADHD〉. Brown TE. 《ADHD Comorbidities: Handbook for ADHD Complications in Children and Adults》 1판. Washington, DC: American Psychiatric Publishing. 32쪽. ISBN 978-1-58562-158-3. OCLC 244601824.
Stanford C, Tannock R (2012년 2월 29일). 《Behavioral Neurobiology of Attention Deficit Hyperactivity Disorder and Its Treatment》. Springer. 10–쪽. ISBN 978-3-642-24611-1.
Ryan N, McDougall T (2009). 《Nursing Children and Young People with ADHD》. Taylor & Francis. 6쪽. ISBN 9781134052196.

caddra.ca

“Canadian ADHD Practice Guidelines | CADDRA” (캐나다 영어). 2020년 10월 27일에 원본 문서에서 보존된 문서. 2020년 10월 24일에 확인함.

cdc.gov

CDC (2019년 10월 8일). “Treatment of ADHD”. 《Centers for Disease Control and Prevention》 (미국 영어). 2019년 11월 20일에 확인함.
Division of Human Development, National Center on Birth Defects and Developmental Disabilities (2014년 9월 29일). “Attention-Deficit / Hyperactivity Disorder (ADHD): Symptoms and Diagnosis”. 《Centers for Disease Control and Prevention》.

doctorlisafairweather.com

“Adult ADHD Help Near Fort Worth, Texas”. 《Dr. Lisa Fairweather》. Fairweather Medical Group in Colleyville, Texas. 2014년 10월 27일에 확인함.

doi.org

dx.doi.org

Zametkin AJ, Nordahl TE, Gross M, King AC, Semple WE, Rumsey J, 외. (November 1990). “Cerebral glucose metabolism in adults with hyperactivity of childhood onset”. 《The New England Journal of Medicine》 323 (20): 1361–6. doi:10.1056/nejm199011153232001. PMID 2233902.
Kooij SJ, Bejerot S, Blackwell A, Caci H, Casas-Brugué M, Carpentier PJ, 외. (September 2010). “European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD”. 《BMC Psychiatry》 10: 67. doi:10.1186/1471-244X-10-67. PMC 2942810. PMID 20815868.
Kooij JJ, Bijlenga D, Salerno L, Jaeschke R, Bitter I, Balázs J, 외. (February 2019). “Updated European Consensus Statement on diagnosis and treatment of adult ADHD”. 《European Psychiatry》 56: 14–34. doi:10.1016/j.eurpsy.2018.11.001. PMID 30453134.
Palmini A (2008). “Professionally successful adults with attention-deficit/hyperactivity disorder (ADHD): Compensation strategies and subjective effects of pharmacological treatment”. 《Dementia & Neuropsychologia》 2 (1): 63–70. doi:10.1590/S1980-57642009DN20100013. PMC 5619157. PMID 29213543.
Faraone SV, Biederman J, Spencer T, Wilens T, Seidman LJ, Mick E, Doyle AE (July 2000). “Attention-deficit/hyperactivity disorder in adults: an overview”. 《Biological Psychiatry》 48 (1): 9–20. doi:10.1016/S0006-3223(00)00889-1. PMID 10913503. S2CID 15987079.
Asherson P, Agnew-Blais J (2019). “Annual Research Review: Does late-onset attention-deficit/hyperactivity disorder exist?”. 《J Child Psychol Psychiatry》 60 (4): 333–352. doi:10.1111/jcpp.13020. PMID 30843223.
Canu, Will H.; Carlson, Caryn L. (February 2007). “Rejection Sensitivity and Social Outcomes of Young Adult Men With ADHD”. 《Journal of Attention Disorders》 (영어) 10 (3): 261–275. doi:10.1177/1087054706288106. ISSN 1087-0547. PMID 17242422. S2CID 13075029.
Bjerrum MB, Pedersen PU, Larsen P (April 2017). “Living with symptoms of attention deficit hyperactivity disorder in adulthood: a systematic review of qualitative evidence”. 《JBI Database of Systematic Reviews and Implementation Reports》 15 (4): 1080–1153. doi:10.11124/JBISRIR-2017-003357. PMID 28398986. S2CID 35553368.
Curatolo P, D'Agati E, Moavero R (December 2010). “The neurobiological basis of ADHD”. 《Italian Journal of Pediatrics》 36 (1): 79. doi:10.1186/1824-7288-36-79. PMC 3016271. PMID 21176172.
Hollis, Chris (June 2018). “ADHD and transitions to adult mental health services”. 《Oxford Medicine Online》. doi:10.1093/med/9780198739258.003.0043. ISBN 978-0-19-180225-6.
Katragadda S, Schubiner H (June 2007). “ADHD in children, adolescents, and adults”. 《Primary Care》 34 (2): 317–41; abstract viii. doi:10.1016/j.pop.2007.04.012. PMID 17666230.
Eden GF, Vaidya CJ (December 2008). “ADHD and developmental dyslexia: two pathways leading to impaired learning”. 《Annals of the New York Academy of Sciences》 1145: 316–27. doi:10.1196/annals.1416.022. PMID 19076406. S2CID 45481868.
McKeague L, Hennessy E, O'Driscoll C, Heary C (June 2015). “Retrospective accounts of self-stigma experienced by young people with attention-deficit/hyperactivity disorder (ADHD) or depression”. 《Psychiatric Rehabilitation Journal》 38 (2): 158–163. doi:10.1037/prj0000121. PMID 25799297.
Fritz, Kathryn M.; O'connor, Patrick J. (June 2016). “Acute Exercise Improves Mood and Motivation in Young Men with ADHD Symptoms”. 《Medicine & Science in Sports & Exercise》 (미국 영어) 48 (6): 1153–1160. doi:10.1249/MSS.0000000000000864. ISSN 0195-9131. PMID 26741120.
Hodgkins P, Arnold LE, Shaw M, Caci H, Kahle J, Woods AG, Young S (2012년 1월 18일). “A systematic review of global publication trends regarding long-term outcomes of ADHD”. 《Frontiers in Psychiatry》 2: 84. doi:10.3389/fpsyt.2011.00084. PMC 3260478. PMID 22279437.
Antshel KM, Hargrave TM, Simonescu M, Kaul P, Hendricks K, Faraone SV (June 2011). “Advances in understanding and treating ADHD”. 《BMC Medicine》 9: 72. doi:10.1186/1741-7015-9-72. PMC 3126733. PMID 21658285.
Madras BK, Miller GM, Fischman AJ (March 2002). “The dopamine transporter: relevance to attention deficit hyperactivity disorder (ADHD)”. 《Behavioural Brain Research》 130 (1–2): 57–63. doi:10.1016/S0166-4328(01)00439-9. PMID 11864718. S2CID 6512707.
Bannon MJ (May 2005). “The dopamine transporter: role in neurotoxicity and human disease”. 《Toxicology and Applied Pharmacology》 204 (3): 355–60. doi:10.1016/j.taap.2004.08.013. PMID 15845424.
Schweitzer JB, Hanford RB, Medoff DR (December 2006). “Working memory deficits in adults with ADHD: is there evidence for subtype differences?”. 《Behavioral and Brain Functions》 2: 43. doi:10.1186/1744-9081-2-43. PMC 1762010. PMID 17173676.
Kim S, Liu Z, Glizer D, Tannock R, Woltering S (August 2014). “Adult ADHD and working memory: neural evidence of impaired encoding”. 《Clinical Neurophysiology》 125 (8): 1596–603. doi:10.1016/j.clinph.2013.12.094. PMID 24411642. S2CID 25814844.
Missonnier P, Hasler R, Perroud N, Herrmann FR, Millet P, Richiardi J, 외. (June 2013). “EEG anomalies in adult ADHD subjects performing a working memory task”. 《Neuroscience》 241: 135–46. doi:10.1016/j.neuroscience.2013.03.011. PMID 23518223. S2CID 937794.
Kieling C, Kieling RR, Rohde LA, Frick PJ, Moffitt T, Nigg JT, 외. (January 2010). “The age at onset of attention deficit hyperactivity disorder”. 《The American Journal of Psychiatry》 167 (1): 14–6. doi:10.1176/appi.ajp.2009.09060796. PMC 4478075. PMID 20068122.
Moffitt TE, Houts R, Asherson P, Belsky DW, Corcoran DL, Hammerle M; 외. (2015). “Is Adult ADHD a Childhood-Onset Neurodevelopmental Disorder? Evidence From a Four-Decade Longitudinal Cohort Study.”. 《Am J Psychiatry》 172 (10): 967–77. doi:10.1176/appi.ajp.2015.14101266. PMC 4591104. PMID 25998281. CS1 관리 - 여러 이름 (링크)
Faraone SV, Biederman J (September 2002). “Efficacy of Adderall for Attention-Deficit/Hyperactivity Disorder: a meta-analysis”. 《Journal of Attention Disorders》 6 (2): 69–75. doi:10.1177/108705470200600203. PMID 12142863. S2CID 33187299.
Elliott J, Johnston A, Husereau D, Kelly SE, Eagles C, Charach A, 외. (2020년 10월 21일). “Pharmacologic treatment of attention deficit hyperactivity disorder in adults: A systematic review and network meta-analysis”. 《PLOS ONE》 15 (10): e0240584. Bibcode:2020PLoSO..1540584E. doi:10.1371/journal.pone.0240584. PMC 7577505. PMID 33085721.
Retz W, Retz-Junginger P, Thome J, Rösler M (September 2011). “Pharmacological treatment of adult ADHD in Europe”. 《The World Journal of Biological Psychiatry》. 12 Suppl 1: 89–94. doi:10.3109/15622975.2011.603229. PMID 21906003. S2CID 34871481.
Godfrey J (March 2009). “Safety of therapeutic methylphenidate in adults: a systematic review of the evidence”. 《Journal of Psychopharmacology》 23 (2): 194–205. doi:10.1177/0269881108089809. PMID 18515459. S2CID 5390805.
Bolea-Alamañac B, Nutt DJ, Adamou M, Asherson P, Bazire S, Coghill D, 외. (March 2014). “Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: update on recommendations from the British Association for Psychopharmacology”. 《Journal of Psychopharmacology》 28 (3): 179–203. doi:10.1177/0269881113519509. PMID 24526134. S2CID 28503360.
Simpson D, Plosker GL (2004). “Spotlight on atomoxetine in adults with attention-deficit hyperactivity disorder”. 《CNS Drugs》 18 (6): 397–401. doi:10.2165/00023210-200418060-00011. PMID 15089111. S2CID 23171429.
Santosh PJ, Sattar S, Canagaratnam M (September 2011). “Efficacy and tolerability of pharmacotherapies for attention-deficit hyperactivity disorder in adults”. 《CNS Drugs》 25 (9): 737–63. doi:10.2165/11593070-000000000-00000. PMID 21870887. S2CID 207300617.
Wilens TE, Morrison NR, Prince J (October 2011). “An update on the pharmacotherapy of attention-deficit/hyperactivity disorder in adults”. 《Expert Review of Neurotherapeutics》 11 (10): 1443–65. doi:10.1586/ern.11.137. PMC 3229037. PMID 21955201.
Verbeeck W, Tuinier S, Bekkering GE (February 2009). “Antidepressants in the treatment of adult attention-deficit hyperactivity disorder: a systematic review”. 《Advances in Therapy》 26 (2): 170–84. doi:10.1007/s12325-009-0008-7. PMID 19238340. S2CID 5975939.
Rösler M, Casas M, Konofal E, Buitelaar J (August 2010). “Attention deficit hyperactivity disorder in adults”. 《The World Journal of Biological Psychiatry》 11 (5): 684–98. doi:10.3109/15622975.2010.483249. PMID 20521876. S2CID 25802733.
Knouse LE, Safren SA (September 2010). “Current status of cognitive behavioral therapy for adult attention-deficit hyperactivity disorder”. 《The Psychiatric Clinics of North America》 33 (3): 497–509. doi:10.1016/j.psc.2010.04.001. PMC 2909688. PMID 20599129.
de Graaf R, Kessler RC, Fayyad J, ten Have M, Alonso J, Angermeyer M, 외. (December 2008). “The prevalence and effects of adult attention-deficit/hyperactivity disorder (ADHD) on the performance of workers: results from the WHO World Mental Health Survey Initiative”. 《Occupational and Environmental Medicine》 65 (12): 835–42. doi:10.1136/oem.2007.038448. PMC 2665789. PMID 18505771.
Kessler RC, Adler L, Barkley R, Biederman J, Conners CK, Demler O, 외. (April 2006). “The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication”. 《The American Journal of Psychiatry》 163 (4): 716–23. doi:10.1176/appi.ajp.163.4.716. PMC 2859678. PMID 16585449.
Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA (June 2007). “The worldwide prevalence of ADHD: a systematic review and metaregression analysis”. 《The American Journal of Psychiatry》 164 (6): 942–8. doi:10.1176/appi.ajp.164.6.942. PMID 17541055.
Willcutt EG (July 2012). “The prevalence of DSM-IV attention-deficit/hyperactivity disorder: a meta-analytic review”. 《Neurotherapeutics》 9 (3): 490–9. doi:10.1007/s13311-012-0135-8. PMC 3441936. PMID 22976615.
Fayyad J, De Graaf R, Kessler R, Alonso J, Angermeyer M, Demyttenaere K, 외. (May 2007). “Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder”. 《The British Journal of Psychiatry》 190 (5): 402–9. doi:10.1192/bjp.bp.106.034389. PMID 17470954.
Berrios GE (December 2006). “'Mind in general' by Sir Alexander Crichton” (PDF). 《History of Psychiatry》 17 (68 Pt 4): 469–86. doi:10.1177/0957154x06071679. PMID 17333675. S2CID 6101515.
Lange KW, Reichl S, Lange KM, Tucha L, Tucha O (December 2010). “The history of attention deficit hyperactivity disorder”. 《Attention Deficit and Hyperactivity Disorders》 2 (4): 241–55. doi:10.1007/s12402-010-0045-8. PMC 3000907. PMID 21258430.
Cormier E (October 2008). “Attention deficit/hyperactivity disorder: a review and update”. 《Journal of Pediatric Nursing》 23 (5): 345–57. doi:10.1016/j.pedn.2008.01.003. PMID 18804015.

dsm5.org

“314.0x Attention Deficit/Hyperactivity Disorder: Proposed Revision”. 《DSM-5 Development》. American Psychiatric Association. 2010년 5월 20일. 2010년 12월 4일에 원본 문서에서 보존된 문서.

ed.gov

Office of Civil Rights (2012년 6월 25일). “Questions and Answers on Disability Discrimination under Section 504 and Title II”. 《U.S. Department of Education》.

eeoc.gov

ADA Division, Office of Legal Counsel (2002년 10월 22일). “Enforcement Guidance: Reasonable Accommodation and Undue Hardship Under the Americans with Disabilities Act”. 《The U.S. Equal Employment Opportunity Commission》.

harvard.edu

adsabs.harvard.edu

Elliott J, Johnston A, Husereau D, Kelly SE, Eagles C, Charach A, 외. (2020년 10월 21일). “Pharmacologic treatment of attention deficit hyperactivity disorder in adults: A systematic review and network meta-analysis”. 《PLOS ONE》 15 (10): e0240584. Bibcode:2020PLoSO..1540584E. doi:10.1371/journal.pone.0240584. PMC 7577505. PMID 33085721.

healingwell.com

news.healingwell.com

Reinberg S (2004년 9월 9일). “Adult ADHD Costs Billions in Lost Income”. 《HealingWell》. 2019년 1월 29일에 원본 문서에서 보존된 문서. 2021년 9월 12일에 확인함.

lww.com

journals.lww.com

Fritz, Kathryn M.; O'connor, Patrick J. (June 2016). “Acute Exercise Improves Mood and Motivation in Young Men with ADHD Symptoms”. 《Medicine & Science in Sports & Exercise》 (미국 영어) 48 (6): 1153–1160. doi:10.1249/MSS.0000000000000864. ISSN 0195-9131. PMID 26741120.

nasponline.org

DuPaul GJ (2004). 〈ADHD Identification and Assessment: Basic Guidelines for Educators〉 (PDF). Canter AS, Paige LZ, Roth MD, Romero I, Carroll SA. 《Helping Children at Home and School II: Handouts for Families and Educators》. Bethesda, MD: NASP Publications. S8–17–S8–19쪽. ISBN 978-0-932955-82-1.

neuropsychiatryreviews.com

Kubose S (February 2000). “ADHD in Adults: Are the current Diagnostic Criteria Adequate?”. 《NeuroPsychiatry Reviews》 1 (1). 2008년 9월 21일에 원본 문서에서 보존된 문서. 2008년 10월 1일에 확인함.

nih.gov

ncbi.nlm.nih.gov

Zametkin AJ, Nordahl TE, Gross M, King AC, Semple WE, Rumsey J, 외. (November 1990). “Cerebral glucose metabolism in adults with hyperactivity of childhood onset”. 《The New England Journal of Medicine》 323 (20): 1361–6. doi:10.1056/nejm199011153232001. PMID 2233902.
Kooij SJ, Bejerot S, Blackwell A, Caci H, Casas-Brugué M, Carpentier PJ, 외. (September 2010). “European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD”. 《BMC Psychiatry》 10: 67. doi:10.1186/1471-244X-10-67. PMC 2942810. PMID 20815868.
Kooij JJ, Bijlenga D, Salerno L, Jaeschke R, Bitter I, Balázs J, 외. (February 2019). “Updated European Consensus Statement on diagnosis and treatment of adult ADHD”. 《European Psychiatry》 56: 14–34. doi:10.1016/j.eurpsy.2018.11.001. PMID 30453134.
Gentile JP, Atiq R, Gillig PM (August 2006). “Adult ADHD: Diagnosis, Differential Diagnosis, and Medication Management”. 《Psychiatry》 3 (8): 25–30. PMC 2957278. PMID 20963192.
Palmini A (2008). “Professionally successful adults with attention-deficit/hyperactivity disorder (ADHD): Compensation strategies and subjective effects of pharmacological treatment”. 《Dementia & Neuropsychologia》 2 (1): 63–70. doi:10.1590/S1980-57642009DN20100013. PMC 5619157. PMID 29213543.
Faraone SV, Biederman J, Spencer T, Wilens T, Seidman LJ, Mick E, Doyle AE (July 2000). “Attention-deficit/hyperactivity disorder in adults: an overview”. 《Biological Psychiatry》 48 (1): 9–20. doi:10.1016/S0006-3223(00)00889-1. PMID 10913503. S2CID 15987079.
Asherson P, Agnew-Blais J (2019). “Annual Research Review: Does late-onset attention-deficit/hyperactivity disorder exist?”. 《J Child Psychol Psychiatry》 60 (4): 333–352. doi:10.1111/jcpp.13020. PMID 30843223.
Canu, Will H.; Carlson, Caryn L. (February 2007). “Rejection Sensitivity and Social Outcomes of Young Adult Men With ADHD”. 《Journal of Attention Disorders》 (영어) 10 (3): 261–275. doi:10.1177/1087054706288106. ISSN 1087-0547. PMID 17242422. S2CID 13075029.
Bjerrum MB, Pedersen PU, Larsen P (April 2017). “Living with symptoms of attention deficit hyperactivity disorder in adulthood: a systematic review of qualitative evidence”. 《JBI Database of Systematic Reviews and Implementation Reports》 15 (4): 1080–1153. doi:10.11124/JBISRIR-2017-003357. PMID 28398986. S2CID 35553368.
Curatolo P, D'Agati E, Moavero R (December 2010). “The neurobiological basis of ADHD”. 《Italian Journal of Pediatrics》 36 (1): 79. doi:10.1186/1824-7288-36-79. PMC 3016271. PMID 21176172.
Valdizán JR, Izaguerri-Gracia AC (February 2009). “[Attention deficit hyperactivity disorder in adults]” [Attention deficit hyperactivity disorder in adults]. 《Revista de Neurología》 (스페인어). 48 Suppl 2 (Suppl 2): S95–9. PMID 19280582.
Katragadda S, Schubiner H (June 2007). “ADHD in children, adolescents, and adults”. 《Primary Care》 34 (2): 317–41; abstract viii. doi:10.1016/j.pop.2007.04.012. PMID 17666230.
Eden GF, Vaidya CJ (December 2008). “ADHD and developmental dyslexia: two pathways leading to impaired learning”. 《Annals of the New York Academy of Sciences》 1145: 316–27. doi:10.1196/annals.1416.022. PMID 19076406. S2CID 45481868.
McKeague L, Hennessy E, O'Driscoll C, Heary C (June 2015). “Retrospective accounts of self-stigma experienced by young people with attention-deficit/hyperactivity disorder (ADHD) or depression”. 《Psychiatric Rehabilitation Journal》 38 (2): 158–163. doi:10.1037/prj0000121. PMID 25799297.
Fritz, Kathryn M.; O'connor, Patrick J. (June 2016). “Acute Exercise Improves Mood and Motivation in Young Men with ADHD Symptoms”. 《Medicine & Science in Sports & Exercise》 (미국 영어) 48 (6): 1153–1160. doi:10.1249/MSS.0000000000000864. ISSN 0195-9131. PMID 26741120.
Hodgkins P, Arnold LE, Shaw M, Caci H, Kahle J, Woods AG, Young S (2012년 1월 18일). “A systematic review of global publication trends regarding long-term outcomes of ADHD”. 《Frontiers in Psychiatry》 2: 84. doi:10.3389/fpsyt.2011.00084. PMC 3260478. PMID 22279437.
Antshel KM, Hargrave TM, Simonescu M, Kaul P, Hendricks K, Faraone SV (June 2011). “Advances in understanding and treating ADHD”. 《BMC Medicine》 9: 72. doi:10.1186/1741-7015-9-72. PMC 3126733. PMID 21658285.
Madras BK, Miller GM, Fischman AJ (March 2002). “The dopamine transporter: relevance to attention deficit hyperactivity disorder (ADHD)”. 《Behavioural Brain Research》 130 (1–2): 57–63. doi:10.1016/S0166-4328(01)00439-9. PMID 11864718. S2CID 6512707.
Bannon MJ (May 2005). “The dopamine transporter: role in neurotoxicity and human disease”. 《Toxicology and Applied Pharmacology》 204 (3): 355–60. doi:10.1016/j.taap.2004.08.013. PMID 15845424.
Schweitzer JB, Hanford RB, Medoff DR (December 2006). “Working memory deficits in adults with ADHD: is there evidence for subtype differences?”. 《Behavioral and Brain Functions》 2: 43. doi:10.1186/1744-9081-2-43. PMC 1762010. PMID 17173676.
Kim S, Liu Z, Glizer D, Tannock R, Woltering S (August 2014). “Adult ADHD and working memory: neural evidence of impaired encoding”. 《Clinical Neurophysiology》 125 (8): 1596–603. doi:10.1016/j.clinph.2013.12.094. PMID 24411642. S2CID 25814844.
Missonnier P, Hasler R, Perroud N, Herrmann FR, Millet P, Richiardi J, 외. (June 2013). “EEG anomalies in adult ADHD subjects performing a working memory task”. 《Neuroscience》 241: 135–46. doi:10.1016/j.neuroscience.2013.03.011. PMID 23518223. S2CID 937794.
Kieling C, Kieling RR, Rohde LA, Frick PJ, Moffitt T, Nigg JT, 외. (January 2010). “The age at onset of attention deficit hyperactivity disorder”. 《The American Journal of Psychiatry》 167 (1): 14–6. doi:10.1176/appi.ajp.2009.09060796. PMC 4478075. PMID 20068122.
Moffitt TE, Houts R, Asherson P, Belsky DW, Corcoran DL, Hammerle M; 외. (2015). “Is Adult ADHD a Childhood-Onset Neurodevelopmental Disorder? Evidence From a Four-Decade Longitudinal Cohort Study.”. 《Am J Psychiatry》 172 (10): 967–77. doi:10.1176/appi.ajp.2015.14101266. PMC 4591104. PMID 25998281. CS1 관리 - 여러 이름 (링크)
Faraone SV, Biederman J (September 2002). “Efficacy of Adderall for Attention-Deficit/Hyperactivity Disorder: a meta-analysis”. 《Journal of Attention Disorders》 6 (2): 69–75. doi:10.1177/108705470200600203. PMID 12142863. S2CID 33187299.
Elliott J, Johnston A, Husereau D, Kelly SE, Eagles C, Charach A, 외. (2020년 10월 21일). “Pharmacologic treatment of attention deficit hyperactivity disorder in adults: A systematic review and network meta-analysis”. 《PLOS ONE》 15 (10): e0240584. Bibcode:2020PLoSO..1540584E. doi:10.1371/journal.pone.0240584. PMC 7577505. PMID 33085721.
Searight HR, Burke JM, Rottnek F (November 2000). “Adult ADHD: evaluation and treatment in family medicine”. 《American Family Physician》 62 (9): 2077–86, 2091–2. PMID 11087189.
Retz W, Retz-Junginger P, Thome J, Rösler M (September 2011). “Pharmacological treatment of adult ADHD in Europe”. 《The World Journal of Biological Psychiatry》. 12 Suppl 1: 89–94. doi:10.3109/15622975.2011.603229. PMID 21906003. S2CID 34871481.
Godfrey J (March 2009). “Safety of therapeutic methylphenidate in adults: a systematic review of the evidence”. 《Journal of Psychopharmacology》 23 (2): 194–205. doi:10.1177/0269881108089809. PMID 18515459. S2CID 5390805.
Bolea-Alamañac B, Nutt DJ, Adamou M, Asherson P, Bazire S, Coghill D, 외. (March 2014). “Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: update on recommendations from the British Association for Psychopharmacology”. 《Journal of Psychopharmacology》 28 (3): 179–203. doi:10.1177/0269881113519509. PMID 24526134. S2CID 28503360.
Simpson D, Plosker GL (2004). “Spotlight on atomoxetine in adults with attention-deficit hyperactivity disorder”. 《CNS Drugs》 18 (6): 397–401. doi:10.2165/00023210-200418060-00011. PMID 15089111. S2CID 23171429.
Santosh PJ, Sattar S, Canagaratnam M (September 2011). “Efficacy and tolerability of pharmacotherapies for attention-deficit hyperactivity disorder in adults”. 《CNS Drugs》 25 (9): 737–63. doi:10.2165/11593070-000000000-00000. PMID 21870887. S2CID 207300617.
Wilens TE, Morrison NR, Prince J (October 2011). “An update on the pharmacotherapy of attention-deficit/hyperactivity disorder in adults”. 《Expert Review of Neurotherapeutics》 11 (10): 1443–65. doi:10.1586/ern.11.137. PMC 3229037. PMID 21955201.
Verbeeck W, Tuinier S, Bekkering GE (February 2009). “Antidepressants in the treatment of adult attention-deficit hyperactivity disorder: a systematic review”. 《Advances in Therapy》 26 (2): 170–84. doi:10.1007/s12325-009-0008-7. PMID 19238340. S2CID 5975939.
Rösler M, Casas M, Konofal E, Buitelaar J (August 2010). “Attention deficit hyperactivity disorder in adults”. 《The World Journal of Biological Psychiatry》 11 (5): 684–98. doi:10.3109/15622975.2010.483249. PMID 20521876. S2CID 25802733.
Knouse LE, Safren SA (September 2010). “Current status of cognitive behavioral therapy for adult attention-deficit hyperactivity disorder”. 《The Psychiatric Clinics of North America》 33 (3): 497–509. doi:10.1016/j.psc.2010.04.001. PMC 2909688. PMID 20599129.
de Graaf R, Kessler RC, Fayyad J, ten Have M, Alonso J, Angermeyer M, 외. (December 2008). “The prevalence and effects of adult attention-deficit/hyperactivity disorder (ADHD) on the performance of workers: results from the WHO World Mental Health Survey Initiative”. 《Occupational and Environmental Medicine》 65 (12): 835–42. doi:10.1136/oem.2007.038448. PMC 2665789. PMID 18505771.
Kessler RC, Adler L, Barkley R, Biederman J, Conners CK, Demler O, 외. (April 2006). “The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication”. 《The American Journal of Psychiatry》 163 (4): 716–23. doi:10.1176/appi.ajp.163.4.716. PMC 2859678. PMID 16585449.
Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA (June 2007). “The worldwide prevalence of ADHD: a systematic review and metaregression analysis”. 《The American Journal of Psychiatry》 164 (6): 942–8. doi:10.1176/appi.ajp.164.6.942. PMID 17541055.
Willcutt EG (July 2012). “The prevalence of DSM-IV attention-deficit/hyperactivity disorder: a meta-analytic review”. 《Neurotherapeutics》 9 (3): 490–9. doi:10.1007/s13311-012-0135-8. PMC 3441936. PMID 22976615.
Fayyad J, De Graaf R, Kessler R, Alonso J, Angermeyer M, Demyttenaere K, 외. (May 2007). “Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder”. 《The British Journal of Psychiatry》 190 (5): 402–9. doi:10.1192/bjp.bp.106.034389. PMID 17470954.
Berrios GE (December 2006). “'Mind in general' by Sir Alexander Crichton” (PDF). 《History of Psychiatry》 17 (68 Pt 4): 469–86. doi:10.1177/0957154x06071679. PMID 17333675. S2CID 6101515.
Lange KW, Reichl S, Lange KM, Tucha L, Tucha O (December 2010). “The history of attention deficit hyperactivity disorder”. 《Attention Deficit and Hyperactivity Disorders》 2 (4): 241–55. doi:10.1007/s12402-010-0045-8. PMC 3000907. PMID 21258430.
Cormier E (October 2008). “Attention deficit/hyperactivity disorder: a review and update”. 《Journal of Pediatric Nursing》 23 (5): 345–57. doi:10.1016/j.pedn.2008.01.003. PMID 18804015.

pubmed.ncbi.nlm.nih.gov

Bolea-Alamañac B, Nutt DJ, Adamou M, Asherson P, Bazire S, Coghill D, 외. (March 2014). “Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: update on recommendations from the British Association for Psychopharmacology”. 《Journal of Psychopharmacology》 28 (3): 179–203. doi:10.1177/0269881113519509. PMID 24526134. S2CID 28503360.

nimh.nih.gov

“NIMH » Attention-Deficit/Hyperactivity Disorder”. 《www.nimh.nih.gov》. 2019년 11월 20일에 확인함.

sagepub.com

journals.sagepub.com

Canu, Will H.; Carlson, Caryn L. (February 2007). “Rejection Sensitivity and Social Outcomes of Young Adult Men With ADHD”. 《Journal of Attention Disorders》 (영어) 10 (3): 261–275. doi:10.1177/1087054706288106. ISSN 1087-0547. PMID 17242422. S2CID 13075029.

semanticscholar.org

api.semanticscholar.org

Faraone SV, Biederman J, Spencer T, Wilens T, Seidman LJ, Mick E, Doyle AE (July 2000). “Attention-deficit/hyperactivity disorder in adults: an overview”. 《Biological Psychiatry》 48 (1): 9–20. doi:10.1016/S0006-3223(00)00889-1. PMID 10913503. S2CID 15987079.
Canu, Will H.; Carlson, Caryn L. (February 2007). “Rejection Sensitivity and Social Outcomes of Young Adult Men With ADHD”. 《Journal of Attention Disorders》 (영어) 10 (3): 261–275. doi:10.1177/1087054706288106. ISSN 1087-0547. PMID 17242422. S2CID 13075029.
Bjerrum MB, Pedersen PU, Larsen P (April 2017). “Living with symptoms of attention deficit hyperactivity disorder in adulthood: a systematic review of qualitative evidence”. 《JBI Database of Systematic Reviews and Implementation Reports》 15 (4): 1080–1153. doi:10.11124/JBISRIR-2017-003357. PMID 28398986. S2CID 35553368.
Eden GF, Vaidya CJ (December 2008). “ADHD and developmental dyslexia: two pathways leading to impaired learning”. 《Annals of the New York Academy of Sciences》 1145: 316–27. doi:10.1196/annals.1416.022. PMID 19076406. S2CID 45481868.
Madras BK, Miller GM, Fischman AJ (March 2002). “The dopamine transporter: relevance to attention deficit hyperactivity disorder (ADHD)”. 《Behavioural Brain Research》 130 (1–2): 57–63. doi:10.1016/S0166-4328(01)00439-9. PMID 11864718. S2CID 6512707.
Kim S, Liu Z, Glizer D, Tannock R, Woltering S (August 2014). “Adult ADHD and working memory: neural evidence of impaired encoding”. 《Clinical Neurophysiology》 125 (8): 1596–603. doi:10.1016/j.clinph.2013.12.094. PMID 24411642. S2CID 25814844.
Missonnier P, Hasler R, Perroud N, Herrmann FR, Millet P, Richiardi J, 외. (June 2013). “EEG anomalies in adult ADHD subjects performing a working memory task”. 《Neuroscience》 241: 135–46. doi:10.1016/j.neuroscience.2013.03.011. PMID 23518223. S2CID 937794.
Faraone SV, Biederman J (September 2002). “Efficacy of Adderall for Attention-Deficit/Hyperactivity Disorder: a meta-analysis”. 《Journal of Attention Disorders》 6 (2): 69–75. doi:10.1177/108705470200600203. PMID 12142863. S2CID 33187299.
Retz W, Retz-Junginger P, Thome J, Rösler M (September 2011). “Pharmacological treatment of adult ADHD in Europe”. 《The World Journal of Biological Psychiatry》. 12 Suppl 1: 89–94. doi:10.3109/15622975.2011.603229. PMID 21906003. S2CID 34871481.
Godfrey J (March 2009). “Safety of therapeutic methylphenidate in adults: a systematic review of the evidence”. 《Journal of Psychopharmacology》 23 (2): 194–205. doi:10.1177/0269881108089809. PMID 18515459. S2CID 5390805.
Bolea-Alamañac B, Nutt DJ, Adamou M, Asherson P, Bazire S, Coghill D, 외. (March 2014). “Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: update on recommendations from the British Association for Psychopharmacology”. 《Journal of Psychopharmacology》 28 (3): 179–203. doi:10.1177/0269881113519509. PMID 24526134. S2CID 28503360.
Simpson D, Plosker GL (2004). “Spotlight on atomoxetine in adults with attention-deficit hyperactivity disorder”. 《CNS Drugs》 18 (6): 397–401. doi:10.2165/00023210-200418060-00011. PMID 15089111. S2CID 23171429.
Santosh PJ, Sattar S, Canagaratnam M (September 2011). “Efficacy and tolerability of pharmacotherapies for attention-deficit hyperactivity disorder in adults”. 《CNS Drugs》 25 (9): 737–63. doi:10.2165/11593070-000000000-00000. PMID 21870887. S2CID 207300617.
Verbeeck W, Tuinier S, Bekkering GE (February 2009). “Antidepressants in the treatment of adult attention-deficit hyperactivity disorder: a systematic review”. 《Advances in Therapy》 26 (2): 170–84. doi:10.1007/s12325-009-0008-7. PMID 19238340. S2CID 5975939.
Rösler M, Casas M, Konofal E, Buitelaar J (August 2010). “Attention deficit hyperactivity disorder in adults”. 《The World Journal of Biological Psychiatry》 11 (5): 684–98. doi:10.3109/15622975.2010.483249. PMID 20521876. S2CID 25802733.
Berrios GE (December 2006). “'Mind in general' by Sir Alexander Crichton” (PDF). 《History of Psychiatry》 17 (68 Pt 4): 469–86. doi:10.1177/0957154x06071679. PMID 17333675. S2CID 6101515.

uga.edu

kadi.myweb.uga.edu

Moon KF (2004). “Development of the DSM”. 《The History of Psychiatric Classification: From Ancient Egypt to Modern America (A Website composed for the History of Psychology (PSYC 6180) The University of Georgia)》. 2009년 6월 6일에 원본 문서에서 보존된 문서.

web.archive.org

Kubose S (February 2000). “ADHD in Adults: Are the current Diagnostic Criteria Adequate?”. 《NeuroPsychiatry Reviews》 1 (1). 2008년 9월 21일에 원본 문서에서 보존된 문서. 2008년 10월 1일에 확인함.
Moon KF (2004). “Development of the DSM”. 《The History of Psychiatric Classification: From Ancient Egypt to Modern America (A Website composed for the History of Psychology (PSYC 6180) The University of Georgia)》. 2009년 6월 6일에 원본 문서에서 보존된 문서.
“314.0x Attention Deficit/Hyperactivity Disorder: Proposed Revision”. 《DSM-5 Development》. American Psychiatric Association. 2010년 5월 20일. 2010년 12월 4일에 원본 문서에서 보존된 문서.
“Canadian ADHD Practice Guidelines | CADDRA” (캐나다 영어). 2020년 10월 27일에 원본 문서에서 보존된 문서. 2020년 10월 24일에 확인함.
“Breaking News: The Social and Economic Impact of ADHD”. 《American Medical Association》. 2004년 9월 7일. 2004년 10월 22일에 원본 문서에서 보존된 문서.
Reinberg S (2004년 9월 9일). “Adult ADHD Costs Billions in Lost Income”. 《HealingWell》. 2019년 1월 29일에 원본 문서에서 보존된 문서. 2021년 9월 12일에 확인함.

webmd.com

“Attention Deficit Hyperactivity Disorder: ADHD in Adults”. 《WebMD》.
Derrer D. “Conditions Similar to ADHD”. 《WebMD》. WebMD. 2015년 10월 16일에 확인함.

worldcat.org

Anastopoulos AD, Shelton TL (2001년 5월 31일). 《Assessing attention-deficit/hyperactivity disorder》. Topics in Social Psychiatry. New York: Kluwer Academic/Plenum Publishers. ISBN 978-0-306-46388-4. OCLC 51784126.
Hechtman, Lily (2009년 2월 8일). 〈ADHD in Adults〉. Brown, Thomas E. 《ADHD Comorbidities: Handbook for ADHD Complications in Children and Adults》 1판. Washington, DC: American Psychiatric Publishing. 87쪽. ISBN 9781585628339. OCLC 701833161.
Rettew DC, Hudziak JJ (2009). 〈Genetics of ADHD〉. Brown TE. 《ADHD Comorbidities: Handbook for ADHD Complications in Children and Adults》 1판. Washington, DC: American Psychiatric Publishing. 32쪽. ISBN 978-1-58562-158-3. OCLC 244601824.
Canu, Will H.; Carlson, Caryn L. (February 2007). “Rejection Sensitivity and Social Outcomes of Young Adult Men With ADHD”. 《Journal of Attention Disorders》 (영어) 10 (3): 261–275. doi:10.1177/1087054706288106. ISSN 1087-0547. PMID 17242422. S2CID 13075029.
Fritz, Kathryn M.; O'connor, Patrick J. (June 2016). “Acute Exercise Improves Mood and Motivation in Young Men with ADHD Symptoms”. 《Medicine & Science in Sports & Exercise》 (미국 영어) 48 (6): 1153–1160. doi:10.1249/MSS.0000000000000864. ISSN 0195-9131. PMID 26741120.